Type
. Reversal by interleukin-2 of the T cell unresponsiveness of lepromatous leprosy to Mycobacterium leprae. Immunological reviews. 1984;80:77-86.
Type
. In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients. Clinical and experimental immunology. 1984;57(2):315-23.
Type
. The early serodiagnosis of leprosy. I. The use of counterimmunoelectrophoresis and enzyme-linked immunosorbent assay. Revista latinoamericana de microbiologia. 1984;26(3):267-72.
Type
. Validity of the nomenclature of rat leprosy and Mycobacterium lepraemurium. Indian journal of leprosy. 1984;56(3):513-9.
Type
. Cell-mediated immunity in mice treated with Mycobacterium leprae or with macrophages harbouring M. leprae. Annales d'immunologie. 1984;135D(1):39-50.
Type
. Mechanism of immunosuppression in leprosy--macrophage membrane alterations. Journal of clinical & laboratory immunology. 1984;14(3):145-9.
Type
. Pathology of granulomatous diseases. Histiocytic granulomas. International journal of dermatology. 1984;23(6):383-9.
Type
. Leprosy and tuberculosis--an epidemiological comparison. Tubercle. 1984;65(2):137-53.
Type
. Dapsone-resistant leprosy. Leprosy review. 1984;55(2):183.
Type
. C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy. Clinical and experimental immunology [Internet]. 1984;56(3):545-52. Available from: http://ila.ilsl.br/pdfs/v28n2a05.pdf